-
Mid-Size Pharmaceuticals Market Analysis 2025 – Insights For Long-Term Investment & Planning
30 Jun 2025 10:28 GMT
… , Aurobindo Pharma Limited., Cipla Limited, Hikma Pharmaceuticals, Endo International plc, Taisho Pharmaceutical Holdings Co … . Ltd., BioMarin Pharmaceutical Inc., Mallinckrodt …
-
Japan's Oldest Pharma Firm to Be Sold to Bain Capital
13 Jun 2025 06:10 GMT
… During the Taisho period, it built a modern pharmaceutical factory to … Mitsubishi Chemical Group's pharmaceutical segment (essentially Mitsubishi Tanabe) posted … . Other Japanese pharmaceutical companies, such as Sumitomo Pharma under Sumitomo Chemical …
-
5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
22 Jan 2025 18:00 GMT
… & Dohme Corp., Navitor Pharmaceuticals, Inc., Taisho Pharmaceutical Co., Ltd., GH Research Limited … , Novartis Pharmaceuticals, Reckitt Benckiser LLC, Relmada …
-
Investors take issue with Taisho Pharma’s buyout price
15 Jul 2024 13:37 GMT
… have decided to contest Taisho Pharma’s recently announced management … the current offer price.
Taisho announced plans for an … it is considering suing Taisho Pharma directors and special committee … has a small prescription pharma business with products like …
-
Japan's Taisho Pharma faces claim over buyout price in court, Nikkei reports
14 Jul 2024 22:27 GMT
… are contesting the pricing of Taisho Pharmaceutical Holdings' management … newspaper reported on Monday.
Taisho's founding family … that the value of Taisho Pharma';s property holdings … , the report added.
Taisho Pharma could not immediately be reached …
-
Japan's Taisho Pharma faces claim over buyout price from Curi RMB, Oasis
14 Jul 2024 22:25 GMT
… are contesting the pricing of Taisho Pharmaceutical Holdings' management buyout in … forced divestment as minority shareholders.
Taisho Pharma announced plans for the management …
-
Bispecific Antibodies Market Set to Surge to $163.15 Billion by 2032, Driven by a Robust 40.1% CAGR | Roche, Amgen, and Johnson & Johnson at the Forefront: AnalystView Market Insights
22 Jul 2025 07:20 GMT
…
Amgen
Genentech
Akeso, Inc.
Taisho Pharmaceutical
Janssen
Immunocore
Adimab, Innovent Biologics … Roche Ltd.
Sanofi
Regeneron Pharmaceuticals Inc.
Pieris Pharmaceuticals, Inc.
Eli Lilly
… Inc.
Novartis AG
Astellas Pharma Inc.
Celgene Corporation
Others
…
-
Oasis says it opposes Taisho Pharma';s $5 bln management buyout
12 Feb 2024 10:53 GMT
… , said it is opposed to Taisho Pharmaceutical';s $5 billion management … 55 per cent premium to Taisho's share price before … in March that would consolidate Taisho's shares - a … that Oasis has been a Taisho shareholder "for a long …
-
Curi RMB Capital Opposes Taisho Pharmaceutical HD’s Management Buyout
21 Feb 2024 01:45 GMT
… management buyout (“the MBO”) of Taisho Pharmaceutical Holdings Co., Ltd. (4581 … JP, TSE Standard, “Taisho”) because we believe the MBO … per share. We suspect Taisho’s excess cash, including … meeting of shareholders held by Taisho in March.
(End)
About …
-
Global OTC Drug and Dietary Supplements Market Forecasts Indicate Significant Growth
22 Jul 2025 19:47 GMT
… dietary supplements, focusing on pharmacological OTC products. The report … STADA ARZNEIMITTEL AG
TAISHO PHARMACEUTICAL HOLDINGS CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD. … including e-commerce, supermarkets, pharmacies, and retail stores. Regions covered …
About
© 1995-2025